PCVXvs its industry peers
A metric-by-metric comparison of PCVX against SPDR S&P Biotech ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCVX본 종목 | — | — | — | — | — | — | — | — | — | — | — | — |
| MDGL | $11.1B#5 | — | 21.2x#9 | 11.6x#4 | 432.1%#2 | 38.1%#4 | -31.3%#5 | -55.0%#7 | -52.5%#3 | — | — | — |
| TGTX | $7.1B#11 | 16.2x#1 | 12.1x#4 | 11.5x#3 | 87.3%#6 | 1811.1%#1 | 20.0%#3 | 76.7%#1 | 13.9%#1 | — | 31.8%#4 | — |
| INSM | $21.3B#2 | — | 30.3x#10 | 35.2x#7 | 66.7%#7 | -39.7%#8 | -205.6%#7 | -181.1%#10 | -185.1%#5 | 4#1 | -9.5%#6 | — |
| SRRK | $5.5B#14 | — | 19.9x#8 | — | — | -53.7%#10 | — | -137.0%#8 | -901.6%#6 | — | 26.0%#5 | — |
| APGE | $10.0B#7 | — | — | — | — | -40.5%#9 | — | — | — | — | — | — |
| PTGX | $8.5B#9 | — | 13.0x#5 | 184.8x#9 | -89.4%#10 | -147.3%#12 | -343.6%#8 | -19.9%#4 | -33.5%#2 | — | — | — |
| SMMT | $10.4B#6 | — | 16.5x#6 | — | — | -387.8%#13 | — | -171.4%#9 | — | — | -51.8%#7 | — |
| UTHR | $21.9B#1 | 19.1x#2 | 3.7x#1 | 6.9x#2 | 10.6%#8 | 11.7%#5 | 46.9%#2 | 22.6%#2 | — | — | 75.3%#2 | — |
| PRAX | $8.5B#10 | — | 6.0x#2 | — | -100.0%#11 | -65.6%#11 | — | -21.5%#5 | — | — | 464.4%#1 | — |
| ARWR | $12.1B#4 | — | 19.7x#7 | 14.6x#5 | 23258.2%#1 | 99.7%#3 | 11.9%#4 | -0.3%#3 | — | — | — | — |
| COGT | $6.6B#12 | — | 10.9x#3 | 843.3x#10 | -65.0%#9 | -28.6%#6 | -4235.3%#10 | -54.1%#6 | -81.2%#4 | — | — | — |
| BBIO | $15.7B#3 | — | — | 31.2x#6 | 126.3%#4 | — | -104.2%#6 | — | — | — | 68.7%#3 | 0.0%#1 |
| PTCT | $5.7B#13 | — | — | 3.3x#1 | 114.5%#5 | 288.0%#2 | 50.1%#1 | — | — | — | — | — |
| CYTK | $9.5B#8 | — | — | 108.1x#8 | 376.6%#3 | -33.2%#7 | -695.4%#9 | — | — | — | — | — |
Peer set: top holdings of XBI (SPDR S&P Biotech ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice